User profiles for Marc Bertrand
Marc BertrandUniversité de Montréal Verified email at umontreal.ca Cited by 22 |
Characterizing novice behavior associated with learning ultrasound-guided peripheral regional anesthesia
…, JD Gallagher, CW Wiley, ML Bertrand… - Regional Anesthesia & …, 2007 - rapm.bmj.com
Background and Objectives: Ultrasound-guided regional anesthesia is a rapidly growing
field. There exists little information regarding the competencies involved with such a practice. …
field. There exists little information regarding the competencies involved with such a practice. …
S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool
…, M Beucher-Gaudin, M Lonchampt, M Bertrand… - … of Pharmacology and …, 2008 - ASPET
Autotaxin catalyzes the transformation of lyso-phosphatidylcholine in lyso-phosphatidic acid
(LPA). LPA is a phospholipid possessing a large panel of activity, in particular as a motility …
(LPA). LPA is a phospholipid possessing a large panel of activity, in particular as a motility …
Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes
…, M Le Vee, C Boursier-Neyret, M Bertrand… - Drug metabolism and …, 2005 - ASPET
Primary hepatocyte cultures are considered as a useful in vitro system for pharmacological/toxicological
studies. Although expression of drug-metabolizing enzymes and canalicular …
studies. Although expression of drug-metabolizing enzymes and canalicular …
NMR Study of Lithium Transport in Liquid–Ceramic Hybrid Solid Composite Electrolytes
G Foran, A Mery, M Bertrand, S Rousselot… - … Applied Materials & …, 2022 - ACS Publications
Despite their high conductivity, factors such as being fragile enough to face processing
issues and interfacial incompatibility with lithium electrodes are some of the main drawbacks …
issues and interfacial incompatibility with lithium electrodes are some of the main drawbacks …
S29434, a quinone reductase 2 inhibitor: main biochemical and cellular characterization
…, F Nepveu, K Reybier, P Dupuis, M Bertrand… - Molecular …, 2019 - ASPET
Quinone reductase 2 (QR2, EC 1.10.5.1) is an enzyme with a feature that has attracted
attention for several decades: in standard conditions, instead of recognizing NAD(P)H as an …
attention for several decades: in standard conditions, instead of recognizing NAD(P)H as an …
Rapid assessment of drug metabolism in the drug discovery process
M Bertrand, P Jackson, B Walther - European journal of pharmaceutical …, 2000 - Elsevier
For a few years, in vitro models have been used as part of high-throughput screening (HTS)
programs to characterize metabolic stability, drug permeability and drug solubility. This has …
programs to characterize metabolic stability, drug permeability and drug solubility. This has …
Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling
…, R Jochemsen, P Jackson, M Bertrand… - European journal of …, 2000 - Elsevier
A strategy is presented to predict interindividual variation in drug plasma levels in vivo by
the use of physiologically based pharmacokinetic modeling and human in vitro metabolic …
the use of physiologically based pharmacokinetic modeling and human in vitro metabolic …
Solid-phase synthesis of α-substituted 3-bisarylthio N-hydroxy propionamides as specific MMP inhibitors
…, N Kucharczyk, A Loynel, M Bertrand… - Bioorganic & medicinal …, 2002 - Elsevier
… Author links open overlay panel Anne-Marie Chollet a , Thierry Le Diguarher a , Nathalie
Kucharczyk a , Armelle Loynel a , Marc Bertrand c , Gordon Tucker b , Nicolas Guilbaud b …
Kucharczyk a , Armelle Loynel a , Marc Bertrand c , Gordon Tucker b , Nicolas Guilbaud b …
Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors
T Le Diguarher, AM Chollet, M Bertrand… - Journal of medicinal …, 2003 - ACS Publications
The synthesis and structure−activity relationship (SAR) studies of a series of cyclopentane
carboxylic acid matrix metalloproteinase (MMP) inhibitors are described. Potent and specific …
carboxylic acid matrix metalloproteinase (MMP) inhibitors are described. Potent and specific …
Substituted benzocyloheptenes as potent and selective αv integrin antagonists
F Perron-Sierra, D Saint Dizier, M Bertrand… - Bioorganic & medicinal …, 2002 - Elsevier
A novel series of potent and specific α v integrin antagonists has been obtained by aminoalkyl
substitutions on benzocyloheptene acetic acids as a rigid GD bioisostere. The preferred …
substitutions on benzocyloheptene acetic acids as a rigid GD bioisostere. The preferred …